Eyevensys is a private clinical stage biotechnology company that is developing a novel approach for treating ocular diseases.

Our mission is to address critical unmet ophthalmic needs using our first-in-class non-viral gene therapy sustained delivery platform to overcome the limitations of current treatment options—including intravitreal injections, surgery, intravitreal implants and biodegradable formulations.

Visit sponsor site

To view all of our sponsors, please click here